NCT02606409View on ClinicalTrials.gov

Dexmedetomidine Versus Propofol for Prolonged Sedation in Poly Traumatized Mechanically Ventilated Patients

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2015

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Trauma
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine sedation at a starting dose of 0.2-7.0 µg/kg/hour.

DRUG

Propofol

Propofol sedation at a starting dose of 10-70 µg/kg/hour.

Trial Locations (1)

715715

Assiut university hospitals, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT02606409 - Dexmedetomidine Versus Propofol for Prolonged Sedation in Poly Traumatized Mechanically Ventilated Patients | Biotech Hunter | Biotech Hunter